<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from url=(0072)file://H:\My%20Documents\Protein%20of%20the%20Month\Oestrogen\Page_2.htm -->
<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page_2_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page_2_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>64</o:Revision>
  <o:TotalTime>162</o:TotalTime>
  <o:Created>2003-09-01T19:29:00Z</o:Created>
  <o:LastSaved>2003-09-03T15:18:00Z</o:LastSaved>
  <o:Pages>4</o:Pages>
  <o:Words>1442</o:Words>
  <o:Characters>8224</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>68</o:Lines>
  <o:Paragraphs>16</o:Paragraphs>
  <o:CharactersWithSpaces>10099</o:CharactersWithSpaces>
  <o:Version>9.4402</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>150</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:16.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman";
	font-weight:normal;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1037"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/potm/archive.html"
title="To Protein Archive"><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1029" type="#_x0000_t75" style='width:113.25pt;
 height:36.75pt'>
 <v:imagedata src="./Page_2_files/image001.jpg" o:title="InterPro_logo"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=151 height=49
src="./Page_2_files/image001.jpg" v:shapes="_x0000_i1029"><![endif]></a>&nbsp;</p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Oestrogen Receptors<o:p></o:p></span></h1>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=0 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=284 valign=top style='width:213.05pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_i1026" type="#_x0000_t75"
   style='width:340.5pt;height:227.25pt'>
   <v:imagedata src="./Page_2_files/image002.gif" o:title="Oestrogen_binding"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=454 height=303
  src="./Page_2_files/image003.gif" v:shapes="_x0000_i1026"><![endif]></p>
  </td>
  <td width=284 valign=top style='width:213.05pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_i1027" type="#_x0000_t75"
   style='width:315.75pt;height:226.5pt'>
   <v:imagedata src="./Page_2_files/image004.jpg" o:title="Oestrogen_activation_2"/>
  </v:shape><![endif]--><![if !vml]><img border=0 width=421 height=302
  src="./Page_2_files/image005.jpg" v:shapes="_x0000_i1027"><![endif]></p>
  </td>
 </tr>
 <tr>
  <td width=284 valign=top style='width:213.05pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt'>Ligand
  activation of ER mediates gene transcription.<o:p></o:p></span></b></p>
  <p class=MsoBodyText>(NTD = N-teminal domain; DBD = DNA-binding domain&nbsp;;
  HBD = hormne-binding domain)</p>
  <p class=MsoNormal><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt'>Picture
  courtesy of M Danielsen, the Nuclear Receptor Resource Library </span></p>
  </td>
  <td width=284 valign=top style='width:213.05pt;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><b><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt'>Cytoplasmic
  signalling pathways influencing the action of ER.<o:p></o:p></span></b></p>
  <p class=MsoNormal><span lang=DE style='font-size:10.0pt;mso-bidi-font-size:
  12.0pt;mso-ansi-language:DE'>Trends Endocrinol Metab. </span><span
  style='font-size:10.0pt;mso-bidi-font-size:12.0pt'>13(10):422 (2002) P. H.
  Driggers and J. H. Segars. <i>Estrogen action and cytoplasmic signalling
  pathways.<o:p></o:p></i></span></p>
  <p class=MsoNormal><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt'><a
  href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12431838&amp;dopt=Abstract"
  title="P. H. Driggers and J. H. Segars (2002) Trends Endocrinol Metab 13(10):422 Estrogen action and cytoplasmic signaling pathways">PMID:
  12431838</a></span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>How the oestrogen receptors work<o:p></o:p></span></h1>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal style='text-indent:36.0pt'>In the absence of the oestrogen
ligand, the ERs are found in the nucleus within a heat shock protein complex
that inhibits their action.<span style="mso-spacerun: yes">  </span>Upon
binding to hormone, the ligand-binding domain changes shape to displace the
heat shock proteins and to facilitate the binding of cofactors, which act to
promote (coactivators) or inhibit (corepressors) the interaction of the
receptor to its target genes.<span style="mso-spacerun: yes">  </span>The ERs
affect gene expression by either binding directly to DNA target genes through
specific oestrogen response elements (ERE), or by binding to other DNA-bound
transcription factors such as <a
href="http://www.ebi.uniprot.org/entry/P05412"
title="UniProt entry for AP1_HUMAN">AP1</a>, <a
href="http://www.ebi.uniprot.org/entry/P08047"
title="UniProt entry for SP1_HUMAN">SP1</a> or NF-kappaB.<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoNormal style='text-indent:36.0pt'>The ER is also capable of
ligand-independent activity via a variety of intracellular signalling pathways,
including the mitogen-activated protein kinase (MAPK) pathway.<span
style="mso-spacerun: yes">  </span>These signalling pathways exert their
effects through the phosphorylation of the ER by protein kinases, or indirectly
through the regulation of cofactors bound to the ER.<span style="mso-spacerun:
yes">  </span>The signal transduction effects involve non-transcriptional
mechanisms, where cytoplasmic or cell membrane-bound regulatory proteins
undergo steroid-induced changes.<span style="mso-spacerun: yes">  </span>For
instance, the action of ER<span style='font-family:Symbol'>a</span> can be
coupled to epidermal growth factor (EGF) signalling, where the activation of
the <a href="http://www.ebi.uniprot.org/entry/P00533"
title="UniProt entry for EGFR_HUMAN">EGF receptor</a> leads to ER<span
style='font-family:Symbol'>a</span> phosphorylation via the MAPK pathway.<span
style="mso-spacerun: yes">  </span>The phosphorylation of ER<span
style='font-family:Symbol'>a</span> enhances its interaction with <a
href="http://www.ebi.uniprot.org/entry/P12931"
title="UniProt entry for SRC_HUMAN">SRC</a> (steroid receptor coactivator),
and can affect ligand binding, receptor dimerisation and DNA binding.<span
style="mso-spacerun: yes">  </span>A feedback mechanism exists, where oestrogen
can induce the activation of MAPK, which in turn activates the ER to amplify
its signal.<span style="mso-spacerun: yes">  </span>Other signalling proteins
can also activate the ER in a ligand-independent way, including the cAMP-dependent
PKA (protein kinase A) and PKC (protein kinase C).<span style="mso-spacerun:
yes">  </span>The cytoplasmic signalling pathways that effect oestrogen action
produce various cell- and tissue-specific, oestrogenic responses through the
assembly of distinct complexes.<span style="mso-spacerun: yes">  </span>The ER
is, therefore, able to act through several divergent pathways to bring about a
variety of oestrogenic responses.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<table border=1 cellspacing=0 cellpadding=0 style='border-collapse:collapse;
 border:none;mso-border-alt:solid windowtext .5pt;mso-padding-alt:0cm 5.4pt 0cm 5.4pt'>
 <tr>
  <td width=284 valign=top style='width:213.05pt;border:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>
  <p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_s1033" type="#_x0000_t75"
   style='position:absolute;margin-left:0;margin-top:0;width:258.5pt;height:255pt;
   z-index:1;mso-position-horizontal:left;mso-position-vertical:top;
   mso-position-vertical-relative:line' o:allowoverlap="f">
   <v:imagedata src="./Page_2_files/image006.gif" o:title="Oestrogen_cofators"/>
   <w:wrap type="square"/>
  </v:shape><![endif]--><![if !vml]><img width=345 height=340
  src="./Page_2_files/image007.gif" align=left hspace=12 v:shapes="_x0000_s1033"><![endif]></p>
  </td>
  <td width=284 valign=top style='width:213.05pt;border:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
  <p class=MsoNormal><b><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt'>A
  connection map for the human oestrogen receptor.<span style="mso-spacerun:
  yes">  </span>The ER interacts with a large number of proteins that can
  either positively or negatively regulate target gene transcription</span></b><span
  style='font-size:10.0pt;mso-bidi-font-size:12.0pt'>.<o:p></o:p></span></p>
  <p class=MsoNormal><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt'>Reprinted
  from Science 296: 1642-1644 (2002) D. P. McDonnell and J. D. Norris. <i>Connections
  and Regulation of the Human Estrogen Receptor<o:p></o:p></i></span></p>
  <p class=MsoNormal><span style='font-size:10.0pt;mso-bidi-font-size:12.0pt'><a
  href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12040178&amp;dopt=Abstract"
  title="D. P. McDonnell and J. D. Norris (2002) Science 296:1642. Connections and Regulation of the Human Estrogen receptor">PMID:
  12040178</a></span></p>
  </td>
 </tr>
</table>

<h1><span style='color:navy'>Cofactors effect oestrogen receptor action<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>ERs can
interact with a variety of cofactors that modify ER action either by enhancing
(coactivators) or inhibiting (corepressors) target gene transcription.<span
style="mso-spacerun: yes">  </span>Cofactors can bind to either the AF-1 site
at the N-terminus, or to the AF-2 site in the ligand-binding domain.<span
style="mso-spacerun: yes">  </span>Coactivators function in histone acetylation
to alter chromatin structure, and in the recruitment of RNA polymerase II to
the promoter to enhance transcription.<span style="mso-spacerun: yes"> 
</span>Corepressors function in histone deacetylation at the promoter to cause
transcriptional repression, or they can act to block AF-2 activity on the ER
itself to prevent coactivator binding.<span style="mso-spacerun: yes"> 
</span>Cofactors can interact with several other nuclear receptors; as such,
most cofactors are limiting factors, for which nuclear receptors compete with
each other.</p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Several
coactivators that bind to the AF-2 site in ERs have been identified, these
include <a href="http://www.ebi.uniprot.org/entry/P12931"
title="UniProt entry for SRC_HUMAN">SRC</a>, <a
href="http://www.ebi.uniprot.org/entry/Q15596"
title="UniProt entry for NCO2_HUMAN">NCO2</a> (nuclear receptor coactivator
2), and <a href="http://www.ebi.uniprot.org/entry/Q9Y6Q9"
title="UniProt entry for NCO3_HUMAN">NCO3</a> from the p160 family, which act
by recruiting chromatin-modifying enzymes to the DNA-bound receptor; <a
href="http://www.ebi.uniprot.org/entry/Q09472"
title="UniProt entry for P300_HUMAN">p300</a>, <a
href="http://www.ebi.uniprot.org/entry/Q92793"
title="UniProt entry for CBP_HUMAN">CBP</a> (CREB binding protein) and <a
href="http://www.ebi.uniprot.org/entry/Q92831"
title="UniProt entry for PCAF_HUMAN">pCAF</a> (CBP-associated factor) ),
which function as histone acetylases for chromatin remodelling (may not bind ER
directly); <a href="http://www.ebi.uniprot.org/entry/Q15648"
title="UniProt entry for PPRB_HUMAN">PPRB</a> (PPAR binding protein), which
functions to establish a link between the receptor and RNA polymerase II; and
possibly <a href="http://www.ebi.uniprot.org/entry/Q96L73"
title="UniProt entry for NSD1_HUMAN">NSD1</a>, <a
href="http://www.ebi.uniprot.org/entry/O15164"
title="UniProt entry for TF1A_HUMAN">TF1A</a>, <a
href="http://www.ebi.uniprot.org/entry/O00264"
title="UniProt entry for PGC1_HUMAN">PGC-1</a>, and <a
href="http://www.ebi.uniprot.org/entry/Q14686"
title="UniProt entry for NCO6_HUMAN">NCO6</a>.<span style="mso-spacerun:
yes">  </span>Together these coactivators form a complex of proteins at target
gene promoters to facilitate local decondensation of chromatin and the
recruitment of the basal transcriptional machinery.</p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Coactivators
can also bind to the AF-1 site, which is positively affected by MAPK-directed
phosphorylation.<span style="mso-spacerun: yes">  </span>The p160 family of
proteins and CBP bind only weakly to AF-1, but other coactivators show a higher
affinity for the AF-1 site, including the RNA coactivator <a
href="http://www.ebi.uniprot.org/entry/Q9D973"
title="UniProt entry for Q9D973, SRA1">SRA</a> (steroid receptor RNA activator)
and the RNA helicases <a href="http://www.ebi.uniprot.org/entry/P17844"
title="UniProt entry for DDX5_HUMAN">p68</a> and <a
href="http://www.ebi.uniprot.org/entry/Q92841"
title="UniProt entry for DD17_HUMAN">p72</a>. </p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Corepressors
have been identified that bind to the AF-2 site; these include <a
href="http://www.ebi.uniprot.org/entry/P48552"
title="UniProt entry for RI14_HUMAN">RIP140</a> (receptor-interacting
protein), which antagonises SRC coactivators by competing for AF-2 binding; the
orphan nuclear receptor <a
href="http://www.ebi.uniprot.org/entry/Q15466"
title="UniProt entry for SHP_HUMAN">SHP</a>, which promotes corepressor
deacetylase binding; the orphan nuclear receptor <a
href="http://www.ebi.uniprot.org/entry/P51843"
title="UniProt entry for DAX1_HUMAN">DAX-1</a>, which acts as a dominant
negative transcriptional regulator; <a
href="http://www.ebi.uniprot.org/entry/O75376"
title="UniProt entry for NCR1_HUMAN">NCR1</a> (nuclear receptor corepressor)
and <a href="http://www.ebi.uniprot.org/entry/Q9Y618"
title="UniProt entry for NCR2_HUMAN">NCR2</a>, which recruit histone
deacetylases, and may mediate tamoxifen action in tumours; RBM9 (RNA-binding
protein), which acts as a repressor of tamoxifen activity; REA (repressor of
oestrogen action) and RSP5/RPF1.</p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Different
ligands promote the binding of different cofactors.<span style="mso-spacerun:
yes">  </span>Ligands that act as agonists, such as estradiol-17<span
style='font-family:Symbol'>b</span> and diethylstilbestrol, can increase AF-2
activity to enhance coactivator binding, while those that act as antagonists,
such as ICI and raloxifene, can block AF-2 activity to prevent coactivator
binding, or can promote corepressor binding.<span style="mso-spacerun: yes"> 
</span>Ligands can have different effects upon the two ERs, for instance THC
can act as an ER<span style='font-family:Symbol'>a</span> agonist and an ER<span
style='font-family:Symbol'>b</span> antagonist.<span style="mso-spacerun:
yes">  </span>Furthermore, ER<span style='font-family:Symbol'>a</span> and ER<span
style='font-family:Symbol'>b</span> can interact with different affinities with
various cofactors, which contributes to their differing responses.<span
style="mso-spacerun: yes">  </span>Various proteins can regulate cofactor
activity, which in turn affects receptor binding and target gene activity; for
instance, <a href="http://www.ebi.uniprot.org/entry/P12931"
title="UniProt entry for SRC_HUMAN">SRC</a> activity can be increased by
MAPK-mediated phosphorylation, and <a
href="http://www.ebi.uniprot.org/entry/O15164"
title="UniProt entry for TF1A_HUMAN">TF1A</a> activity can be increased by
the methyltransferase <a href="http://www.ebi.uniprot.org/entry/Q9WVG6"
title="UniProt entry for Q9WVG6">CARM1</a>.<span style="mso-spacerun: yes"> 
</span>The overexpression of various cofactors, such as <a
href="http://www.ebi.uniprot.org/entry/Q9Y6Q9"
title="UniProt entry for NCO3_HUMAN">NCO3</a>, <a
href="http://www.ebi.uniprot.org/entry/Q14686"
title="UniProt entry for NCO6_HUMAN">NCO6</a> and <a
href="http://www.ebi.uniprot.org/entry/Q15648"
title="UniProt entry for PPRB_HUMAN">PPRB</a>, has been found in both breast
and ovarian cancers.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h2>Next:<span style="mso-spacerun: yes">  </span><a href="Page_3.htm">The
physiological roles of the oestrogen receptors</a></h2>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal align=center style='text-align:center'><span
style='font-size:16.0pt;mso-bidi-font-size:12.0pt'>Previous:<span
style="mso-spacerun: yes">  </span><a href="Page_1.htm">Oestrogen receptors,
ligand-inducible transcription factors</a><o:p></o:p></span></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal>&nbsp;</p>

</div>

</body>

</html>
